Eyes on New Product Development

J Ocul Pharmacol Ther. 2023 Oct;39(8):475-476. doi: 10.1089/jop.2023.29115.gdn.

Author

Gary D Novack^{1

2}

Affiliations

¹ PharmaLogic Development, Inc., San Rafael, California, USA.
² Department of Ophthalmology and Visual Science, School of Medicine, University of California, Davis, Sacramento, California, USA.

PMID: 37861412
DOI: 10.1089/jop.2023.29115.gdn

No abstract available

MeSH terms

Administration, Ophthalmic
Drug Approval
Drug Design
Eye Diseases* / drug therapy
Eye*
Humans